title: [Neuroleptic metabolic dysfunctions in patients treated with new generation antipsychotics].
authors.forename: L N
authors.initials: LN
authors.lastname: Gorobets
authors.forename: V S
authors.initials: VS
authors.lastname: Bulanov
authors.forename: L M
authors.initials: LM
authors.lastname: Vasilenko
authors.forename: A V
authors.initials: AV
authors.lastname: Litvinov
authors.forename: G P
authors.initials: GP
authors.lastname: Ivanova
authors.forename: T P
authors.initials: TP
authors.lastname: Poliakovskaia
mesh_terms: D058633:Antipyretics / Q000009:adverse effects* / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D050260:Carbohydrate Metabolism / Q000187:drug effects; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D058633:Antipyretics; D003024:Clozapine